Global Children Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to our (Global Info Research) latest study, the global Children Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Children Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Children Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Children Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Children Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Children Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Children Influenza Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Children Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, CSL, GSK, Mylan and Hulan Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Children Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Children Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Children Influenza Vaccine, with price, sales, revenue and global market share of Children Influenza Vaccine from 2018 to 2023.
Chapter 3, the Children Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Children Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Children Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Children Influenza Vaccine.
Chapter 14 and 15, to describe Children Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Children Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Children Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Children Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Children Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Children Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Children Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Children Influenza Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Children Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, CSL, GSK, Mylan and Hulan Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Children Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Nasal Spray
- Injection
- 6 Months to 3 Years
- Over 3 Years
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Children Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Children Influenza Vaccine, with price, sales, revenue and global market share of Children Influenza Vaccine from 2018 to 2023.
Chapter 3, the Children Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Children Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Children Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Children Influenza Vaccine.
Chapter 14 and 15, to describe Children Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Children Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Children Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Nasal Spray
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Children Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 Over 3 Years
1.5 Global Children Influenza Vaccine Market Size & Forecast
1.5.1 Global Children Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Children Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Children Influenza Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Children Influenza Vaccine Product and Services
2.1.4 Sanofi Pasteur Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Children Influenza Vaccine Product and Services
2.2.4 CSL Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Children Influenza Vaccine Product and Services
2.3.4 GSK Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Children Influenza Vaccine Product and Services
2.4.4 Mylan Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Children Influenza Vaccine Product and Services
2.5.4 Hulan Bio Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hulan Bio Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Children Influenza Vaccine Product and Services
2.6.4 AstraZeneca Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Children Influenza Vaccine Product and Services
2.7.4 CCBIO Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CCBIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHILDREN INFLUENZA VACCINE BY MANUFACTURER
3.1 Global Children Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Children Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Children Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Children Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Children Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Children Influenza Vaccine Manufacturer Market Share in 2022
3.5 Children Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Children Influenza Vaccine Market: Region Footprint
3.5.2 Children Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Children Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Children Influenza Vaccine Market Size by Region
4.1.1 Global Children Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Children Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Children Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Children Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Children Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Children Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Children Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Children Influenza Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Children Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Children Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Children Influenza Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Children Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Children Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Children Influenza Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Children Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Children Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Children Influenza Vaccine Market Size by Country
7.3.1 North America Children Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Children Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Children Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Children Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Children Influenza Vaccine Market Size by Country
8.3.1 Europe Children Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Children Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Children Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Children Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Children Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Children Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Children Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Children Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Children Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Children Influenza Vaccine Market Size by Country
10.3.1 South America Children Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Children Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Children Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Children Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Children Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Children Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Children Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Children Influenza Vaccine Market Drivers
12.2 Children Influenza Vaccine Market Restraints
12.3 Children Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Children Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Children Influenza Vaccine
13.3 Children Influenza Vaccine Production Process
13.4 Children Influenza Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Children Influenza Vaccine Typical Distributors
14.3 Children Influenza Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Children Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Children Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Nasal Spray
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Children Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 Over 3 Years
1.5 Global Children Influenza Vaccine Market Size & Forecast
1.5.1 Global Children Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Children Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Children Influenza Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Children Influenza Vaccine Product and Services
2.1.4 Sanofi Pasteur Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Children Influenza Vaccine Product and Services
2.2.4 CSL Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Children Influenza Vaccine Product and Services
2.3.4 GSK Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Children Influenza Vaccine Product and Services
2.4.4 Mylan Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Children Influenza Vaccine Product and Services
2.5.4 Hulan Bio Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hulan Bio Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Children Influenza Vaccine Product and Services
2.6.4 AstraZeneca Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Children Influenza Vaccine Product and Services
2.7.4 CCBIO Children Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CCBIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHILDREN INFLUENZA VACCINE BY MANUFACTURER
3.1 Global Children Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Children Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Children Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Children Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Children Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Children Influenza Vaccine Manufacturer Market Share in 2022
3.5 Children Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Children Influenza Vaccine Market: Region Footprint
3.5.2 Children Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Children Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Children Influenza Vaccine Market Size by Region
4.1.1 Global Children Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Children Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Children Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Children Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Children Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Children Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Children Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Children Influenza Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Children Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Children Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Children Influenza Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Children Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Children Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Children Influenza Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Children Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Children Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Children Influenza Vaccine Market Size by Country
7.3.1 North America Children Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Children Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Children Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Children Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Children Influenza Vaccine Market Size by Country
8.3.1 Europe Children Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Children Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Children Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Children Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Children Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Children Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Children Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Children Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Children Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Children Influenza Vaccine Market Size by Country
10.3.1 South America Children Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Children Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Children Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Children Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Children Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Children Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Children Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Children Influenza Vaccine Market Drivers
12.2 Children Influenza Vaccine Market Restraints
12.3 Children Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Children Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Children Influenza Vaccine
13.3 Children Influenza Vaccine Production Process
13.4 Children Influenza Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Children Influenza Vaccine Typical Distributors
14.3 Children Influenza Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Children Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Children Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Children Influenza Vaccine Product and Services
Table 6. Sanofi Pasteur Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Children Influenza Vaccine Product and Services
Table 11. CSL Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Children Influenza Vaccine Product and Services
Table 16. GSK Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Children Influenza Vaccine Product and Services
Table 21. Mylan Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan Recent Developments/Updates
Table 23. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hulan Bio Major Business
Table 25. Hulan Bio Children Influenza Vaccine Product and Services
Table 26. Hulan Bio Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hulan Bio Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Children Influenza Vaccine Product and Services
Table 31. AstraZeneca Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. CCBIO Basic Information, Manufacturing Base and Competitors
Table 34. CCBIO Major Business
Table 35. CCBIO Children Influenza Vaccine Product and Services
Table 36. CCBIO Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CCBIO Recent Developments/Updates
Table 38. Global Children Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Children Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Children Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Children Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Children Influenza Vaccine Production Site of Key Manufacturer
Table 43. Children Influenza Vaccine Market: Company Product Type Footprint
Table 44. Children Influenza Vaccine Market: Company Product Application Footprint
Table 45. Children Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Children Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Children Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Children Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Children Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Children Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Children Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Children Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Children Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Children Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Children Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Children Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Children Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Children Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Children Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Children Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Children Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Children Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Children Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Children Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Children Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Children Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Children Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Children Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Children Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Children Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Children Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Children Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Children Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Children Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Children Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Children Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Children Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Children Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Children Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Children Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Children Influenza Vaccine Raw Material
Table 106. Key Manufacturers of Children Influenza Vaccine Raw Materials
Table 107. Children Influenza Vaccine Typical Distributors
Table 108. Children Influenza Vaccine Typical Customers
Table 1. Global Children Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Children Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Children Influenza Vaccine Product and Services
Table 6. Sanofi Pasteur Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Children Influenza Vaccine Product and Services
Table 11. CSL Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Children Influenza Vaccine Product and Services
Table 16. GSK Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Children Influenza Vaccine Product and Services
Table 21. Mylan Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan Recent Developments/Updates
Table 23. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hulan Bio Major Business
Table 25. Hulan Bio Children Influenza Vaccine Product and Services
Table 26. Hulan Bio Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hulan Bio Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Children Influenza Vaccine Product and Services
Table 31. AstraZeneca Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. CCBIO Basic Information, Manufacturing Base and Competitors
Table 34. CCBIO Major Business
Table 35. CCBIO Children Influenza Vaccine Product and Services
Table 36. CCBIO Children Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CCBIO Recent Developments/Updates
Table 38. Global Children Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Children Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Children Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Children Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Children Influenza Vaccine Production Site of Key Manufacturer
Table 43. Children Influenza Vaccine Market: Company Product Type Footprint
Table 44. Children Influenza Vaccine Market: Company Product Application Footprint
Table 45. Children Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Children Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Children Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Children Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Children Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Children Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Children Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Children Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Children Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Children Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Children Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Children Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Children Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Children Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Children Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Children Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Children Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Children Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Children Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Children Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Children Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Children Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Children Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Children Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Children Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Children Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Children Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Children Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Children Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Children Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Children Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Children Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Children Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Children Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Children Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Children Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Children Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Children Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Children Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Children Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Children Influenza Vaccine Raw Material
Table 106. Key Manufacturers of Children Influenza Vaccine Raw Materials
Table 107. Children Influenza Vaccine Typical Distributors
Table 108. Children Influenza Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Children Influenza Vaccine Picture
Figure 2. Global Children Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Children Influenza Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Nasal Spray Examples
Figure 5. Injection Examples
Figure 6. Global Children Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Children Influenza Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. Over 3 Years Examples
Figure 10. Global Children Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Children Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Children Influenza Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Children Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Children Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Children Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Children Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Children Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Children Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Children Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Children Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Children Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Children Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Children Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Children Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Children Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Children Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Children Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Children Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Children Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Children Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Children Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Children Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Children Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Children Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Children Influenza Vaccine Market Drivers
Figure 73. Children Influenza Vaccine Market Restraints
Figure 74. Children Influenza Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Children Influenza Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Children Influenza Vaccine
Figure 78. Children Influenza Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Children Influenza Vaccine Picture
Figure 2. Global Children Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Children Influenza Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Nasal Spray Examples
Figure 5. Injection Examples
Figure 6. Global Children Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Children Influenza Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. Over 3 Years Examples
Figure 10. Global Children Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Children Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Children Influenza Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Children Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Children Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Children Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Children Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Children Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Children Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Children Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Children Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Children Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Children Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Children Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Children Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Children Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Children Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Children Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Children Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Children Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Children Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Children Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Children Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Children Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Children Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Children Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Children Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Children Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Children Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Children Influenza Vaccine Market Drivers
Figure 73. Children Influenza Vaccine Market Restraints
Figure 74. Children Influenza Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Children Influenza Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Children Influenza Vaccine
Figure 78. Children Influenza Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
